author-photo

Jennifer R. Eads

University of Pennsylvania

15

Papers

31

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Association between timely targeted therapy initiation and clinical outcomes in patients with advanced HER2+ gastroesophageal adenocarcinoma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of a safety run-in—A trial of the ECOG-ACRIN Cancer Research Group (EA2174).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Primary Chemoradiotherapy for Older Patients With Esophageal Cancer.

2021 JAMA Oncology
- Jennifer R. Eads
- Daniel G. Haller
Show All
- Source
- Cite
- Save
Citations (0)
Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors.

2021
Show All
- Source
- Cite
- Save
Citations (1)
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors.

2020 Pancreas
Show All
- Source
- Cite
- Save
Citations (2)
Phase 1 and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (11)
68Ga-DOTATATE Positron Emission Tomography-Computed Tomography Quantification Predicts Response to Somatostatin Analog Therapy in Gastroenteropancreatic Neuroendocrine Tumors: 68Ga-DOTATATE PET/CT Predicts Response to SSA

2020 Oncologist
Show All
- Source
- Cite
- Save
Citations (0)
Adherence to and determinants of guideline-recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: Insights from routine practice.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
68Ga‐DOTATATE PET/CT quantification predicts response to somatostatin analog therapy in gastroenteropancreatic neuroendocrine tumors

2020 Oncologist
Show All
- Source
- Cite
- Save
Citations (0)
5-fluorouracil enhances the anti-tumor activity of the glutaminase inhibitor CB-839 against PIK3CA-mutant colorectal cancers.

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (13)